Diagnostic accuracy of BRCA1-associated protein 1 in malignant mesothelioma: a meta-analysis
Open Access
- 17 August 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (40) , 68863-68872
Abstract
Diagnostic accuracy of BRCA1–associated protein 1 in malignant mesothelioma: a meta-analysis Diagnostic accuracy of BRCA1–associated protein 1 in malignant mesothelioma: a meta-analysisKeywords
This publication has 40 references indexed in Scilit:
- Low homozygous/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesotheliomaLung Cancer, 2016
- BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesotheliomaHuman Pathology, 2015
- Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest GroupArchives of Pathology & Laboratory Medicine, 2013
- Treatment and survival analyses of malignant mesothelioma in JapanActa Oncologica, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Germline BAP1 mutations predispose to malignant mesotheliomaNature Genetics, 2011
- The diagnostic odds ratio: a single indicator of test performanceJournal of Clinical Epidemiology, 2003
- Immunohistochemical diagnosis of epithelioid mesotheliomas: A critical review of old markers, new markersHuman Pathology, 2002
- Combining independent studies of a diagnostic test into a summary roc curve: Data‐analytic approaches and some additional considerationsStatistics in Medicine, 1993
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986